PAX5 and lymphoplasmacytic lymphoma: The PAX5 t(9;14) recombination is by far the most studied and prevalent PAX5 genetic alteration in non-Hodgkin’s lymphoma subtypes such as lymphoplasmacytic lymphoma (LPL) and DLBCL [11,54,90].